Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Agostino Cervone

Surgery Riverhead, NY Medical Doctor

NPI 1841206018 CMS profile 309796

34 Commerce Ave, Riverhead, NY 11901

Open in the dashboard

General payments

$93,818

142 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Agostino Cervone of Riverhead, NY is reported in the CMS Open Payments database as having received $93,818 across 142 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $7,661 27
2024 General $17,489 29
2023 General $19,427 20
2022 General $40,775 33
2021 General $594 6
2020 General $182 4
2019 General $7,689 23

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Agostino Cervone
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Agostino Cervone were reported at $7,661. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Agostino Cervone Surgery median Middle half National median
2019 $7,689 $253 $82–$1,521 $163
2020 $182 $131 $40–$706 $114
2021 $594 $168 $50–$904 $132
2022 $40,775 $224 $76–$1,218 $149
2023 $19,427 $253 $82–$1,255 $160
2024 $17,489 $279 $90–$1,381 $164
2025 $7,661 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $69,179 76 payments
  2. Surgical Specialties Corporation (US), Inc. $17,650 5 payments
  3. Davol Inc. $3,019 14 payments
  4. Ethicon Inc. $1,000 14 payments
  5. Medtronic, Inc. $382 3 payments
  6. Dilon Technologies, Inc. $342 3 payments
  7. Smith+Nephew, Inc. $340 6 payments
  8. Organogenesis Inc. $244 2 payments
  9. W. L. Gore & Associates, Inc. $242 3 payments
  10. Transenterix, Inc. $240 1 payment
  11. Other $1,179 15 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $52,000 13 payments
  2. Consulting Fee $18,450 19 payments
  3. Travel and Lodging $13,012 35 payments
  4. Food and Beverage $7,954 69 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,850 3 payments
  6. Honoraria $520 1 payment
  7. Gift $31 2 payments
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $68,179 75 payments
  2. DA VINCI SP $1,000 1 payment
  3. Phasix Mesh $848 5 payments
  4. Surgical wound closure product $350 1 payment
  5. HEMOBLAST BELLOWS $342 3 payments
  6. GORE SYNECOR Biomaterial $242 3 payments
  7. Senhance Surgical Robotics System $240 1 payment
  8. TRANSORB $189 1 payment
  9. NOVOSORB BTM $180 1 payment
  10. Signia $148 1 payment
  11. Other $1,465 26 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 61 billing codes

Paid by Medicare

$152,491

Medicare's payments for the services billed

Medicare patients

280

Average age 75

Services billed

621

124 women, 156 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 56%
Ischemic heart disease 36%
Atrial fibrillation 28%
Diabetes 27%
Chronic kidney disease 23%
Cancer 21%
COPD 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

142 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record